+ Follow LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 199977
[Title] => Nothing new in case-control study of long-term HRT, breast cancer
[Summary] => Theres nothing new under the sun.
Thats how doctors view the conclusions of a widely publicized case-control study that examined the long-term effects of hormone replacement therapy (HRT) in relation to breast cancer among more than 700 women who were post-menopausal. The article concluded that the incidence of breast cancer was increased by 60 percent-85 percent in recent long-term users of HRT whether they used estrogen alone or estrogen plus progestin.
[DatePublished] => 2003-03-23 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 199977
[Title] => Nothing new in case-control study of long-term HRT, breast cancer
[Summary] => Theres nothing new under the sun.
Thats how doctors view the conclusions of a widely publicized case-control study that examined the long-term effects of hormone replacement therapy (HRT) in relation to breast cancer among more than 700 women who were post-menopausal. The article concluded that the incidence of breast cancer was increased by 60 percent-85 percent in recent long-term users of HRT whether they used estrogen alone or estrogen plus progestin.
[DatePublished] => 2003-03-23 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
abtest